MED Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 12.48
EPS (TTM)$-1.72-87.2% YoY
Profit margin-5.8%CONSUMER CYCLICAL
Market cap$125.3MMicro cap
Valuation
- Forward P/E
- 12.48
- PEG ratio
- 0.97
- P/B
- 0.63
- P/S (TTM)
- 0.36
- EV/EBITDA
- 0.05
Profitability & growth
- ROE (TTM)
- -9.8%
- Operating margin
- -7.2%
- Revenue growth YoY
- -34.3%
- Dividend yield
- —
- Beta
- 0.66
Last earnings
May 4, 2026 · Estimate $-0.52 · Reported $-0.19
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About MEDIFAST INC
Company profileMedifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Classification
- Sector
- Consumer Cyclical
- Industry
- Personal Services
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1501 S. CLINTON STREET, BALTIMORE, MD
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$125.3M
Shares outstanding$11.1M
52W high$15.46
52W low$9.22
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent